(Natural News) Eli Lilly & Company are halting the enrollment of participants in a clinical trial of its antibody treatment for the Wuhan coronavirus (COVID-19) due to safety concerns. According to company spokeswoman Molly McCully, an independent data and safety monitoring board (DSMB) had recommended pausing enrollment in the U.S. government-sponsored trials. Lilly, however, did not say […]
in: antibody,badhealth,badmedicine,badscience,Big Pharma,coronavirus,covid-19,disease,Donald Trump,drug safety,eli lilly,FDA,Flu,monoclonal antibody,NIH,outbreak,pandemic,Regeneron,side effects,treatment,Trials,virus